Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03250312 · ClinicalTrials.gov registry record · NA
The Effects of OMT on the Expression Patterns of Immune Cell Biomarkers
A NA study, sponsored by A.T. Still University of Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03250312 is a NA study that was terminated before completion, run by A.T. Still University of Health Sciences. The registered enrollment target is 40 participants.
The verdict
NCT03250312, a NA study, was terminated before completion, sponsored by A.T. Still University of Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study intends to understand the effects of osteopathic manipulative treatment (OMT) on the expression patterns of 60 immune cell biomarkers in the peripheral blood mononuclear cells (PBMC) of each participant, before and after intervention - OMT or seated control. This study will utilize participants with a history of low back pain (LBP), and will identify and validate those immune cell biomarkers that change in most participants after OMT, by using the novel protein subcellular localization (PSL) microarray technology. This study intends to uncover the important immune cells affected by OMT techniques, therefore to uncover the molecular mechanisms of OMT.
Interventions
- OTHER The Osteopathic Manipulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2017-09-13 |
| Est. Completion | 2019-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03250312
The ClinicalTrials.gov registry entry for NCT03250312 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is A.T. Still University of Health Sciences, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which The Osteopathic Manipulation is the first listed.
NCT03250312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03250312 about?
NCT03250312 is a clinical study titled "The Effects of OMT on the Expression Patterns of Immune Cell Biomarkers". This study intends to understand the effects of osteopathic manipulative treatment (OMT) on the expression patterns of 60 immune cell biomarkers in the peripheral blood mononuclear cells (PBMC) of each participant, before and after intervention - OMT or seated control. This study will utilize partic...
What is the current status of trial NCT03250312?
This trial is currently terminated. It is a NA study. The enrollment target is 40 participants. The study started on 2017-09-13. Estimated completion is 2019-08-31.
What interventions are being tested in trial NCT03250312?
The interventions under investigation include: The Osteopathic Manipulation (OTHER).
Who is sponsoring clinical trial NCT03250312?
This trial is sponsored by A.T. Still University of Health Sciences, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.